Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Galicia clin ; 84(4): 13-18, Oct.-Nov.-Dec. 2023. tab, graf
Artigo em Inglês | IBECS | ID: ibc-230216

RESUMO

Objectives: The COVID-19 pandemic has affected the global fight against Tuberculosis, although its impact is not fully known. We aimed to analyse the impact of the COVID-19 pandemic on the diagnosis and hospital care of tuberculosis patients. Material and Method: We conducted a retrospective study in a Portuguese 804-bed hospital between March 2019 and March 2021. We compared the number of new diagnoses of active Tuberculosis in hospitalized patients in the 12-month period before (group A) and after (group B) the surge of COVID-19 in Portugal (March 2020), as well as patients’ clinical characteristics. Results: There were a total of 24.675 hospital admissions, of which 158 were due to new active tuberculosis. There were 60 new diagnoses of active tuberculosis in the first year of the COVID-19 pandemic (group B), compared to 98 in the previous year (group A) (0.5% vs. 0.8%, respectively, p=0.004). Gender distribution, age, symptoms at presentation and affected organs were similar in both groups. During the COVID-19 pandemic, there was a significant median 3-day delay in diagnosis after hospital admission (p=0.047) and a total of 18% of tuberculosis cases were co-infected with SARS-CoV-2 in the first month of antituberculosis therapy. Conclusion: During the first year of the COVID-19 pandemic, hospitalised patients were 37% less likely to have a diagnosis of new active TB, compared to the previous year. Our study highlights the concern about underdiagnosis and diagnostic delay of active TB during the COVID-19 pandemic and the need for studies and policies addressing this matter. (AU)


Objetivos: Analizar el impacto de la pandemia de COVID-19 en el diagnóstico y la atención hospitalaria de los pacientes con tuberculosis. Método: Estudio retrospectivo en un hospital portugués de 804 camas entre marzo de 2019 y marzo de 2021. Comparamos el número de nuevos diagnósticos de tuberculosis activa en pacientes hospitalizados en el período de 12 meses antes y después el repunte de la COVID-19 en Portugal (marzo 2020), así como las características clínicas de los pacientes. Resultados: Se incluyeron 24.675 ingresos hospitalarios, de los cuales 158 fueron por tuberculosis activa nueva. Se observó 60 nuevos diagnósticos de tuberculosis activa en el primer año de la pandemia COVID-19 (grupo B), frente a los 98 del año anterior (grupo A) (p=0,004). La distribución por género, edad, presentación y órganos afectados fueron similares. Durante la pandemia de COVID-19, hubo una mediana de retraso significativo de 3 días en el diagnóstico después del ingreso hospitalario (p=0,047) y un total del 18 % de los casos de tuberculosis se infectaron con SARS-CoV-2 en el primer mes de terapia antituberculosa. Conclusión: Durante el primer año de la pandemia COVID-19, los pacientes hospitalizados tuvieron 37% menos de probabilidad de tener un diagnóstico nuevo de TB. Nuestro estudio destaca la preocupación por el infradiagnóstico y el retraso en el diagnóstico de la TB activa durante la pandemia COVID-19 y la necesidad de estudios y políticas que aborden este tema. (AU)


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Pessoa de Meia-Idade , /complicações , /epidemiologia , Tuberculose/complicações , Hospitalização , Pandemias , Portugal , Estudos Retrospectivos
2.
Sleep Med ; 109: 50-55, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37418827

RESUMO

OBJECTIVES: To compare positive airway pressure (PAP) adherence between patients with or without excessive daytime sleepiness (EDS) in mild, moderate and severe obstructive sleep apnea (OSA). METHODS: Patients ≥18 years diagnosed with OSA in 2018 and 2019, without previous history of PAP usage and with adherence registration in the first medical consultation after treatment initiation, were included. EDS was defined as a score of ≥10 on the Epworth Scale. Patients were divided into two groups according to the adherence to PAP: "Adherent" if using the device for ≥4 h for ≥70% of the nights and "Nonadherent" otherwise. Simple and multiple logistic regression models for adherence were determined. RESULTS: 321 patients were included, most male (64.2%), with mean age 56.56 years. Most patients had severe OSA (n = 159; 49.5%), and median AHI was 29.3/h [16.8; 47.5]. Being older or having a severe OSA resulted in an increased adherence (OR = 1.020, CI95% = [1.002; 1.039] and OR = 2.299, CI95% = [1.273; 4.191], respectively). In patients without EDS a statistically significant difference was found in adherence between those with severe OSA and both mild and moderate OSA categories (OR = 0.285, p = 0.023 and OR = 0.387, p = 0.026, respectively), with patients with severe OSA being adherent. There was no statistical difference in adherence between patients with or without EDS (OR 1.083; p = 0.876), nor in the different degrees of severity in those with EDS. CONCLUSION: In our study there were no differences in PAP therapy adherence between patients with or without excessive daytime sleepiness. Older age and higher OSA severity resulted in higher adherence rates.


Assuntos
Distúrbios do Sono por Sonolência Excessiva , Apneia Obstrutiva do Sono , Humanos , Masculino , Pessoa de Meia-Idade , Distúrbios do Sono por Sonolência Excessiva/terapia , Distúrbios do Sono por Sonolência Excessiva/diagnóstico , Polissonografia , Cooperação e Adesão ao Tratamento , Cooperação do Paciente
5.
J Bras Pneumol ; 47(6): e20210124, 2022.
Artigo em Inglês, Português | MEDLINE | ID: mdl-35019054

RESUMO

OBJECTIVE: The identification of persistent airway obstruction is key to making a diagnosis of COPD. The GOLD guidelines suggest a fixed criterion-a post-bronchodilator FEV1/FVC ratio < 70%-to define obstruction, although other guidelines suggest that a post-bronchodilator FEV1/FVC ratio < the lower limit of normal (LLN) is the most accurate criterion. METHODS: This was an observational study of individuals ≥ 40 years of age with risk factors for COPD who were referred to our pulmonary function laboratory for spirometry. Respiratory symptoms were also recorded. We calculated the prevalence of airway obstruction and of no airway obstruction, according to the GOLD criterion (GOLD+ and GOLD-, respectively) and according to the LLN criterion (LLN+ and LLN-, respectively). We also evaluated the level of agreement between the two criteria. RESULTS: A total of 241 individuals were included. Airway obstruction was identified according to the GOLD criterion in 42 individuals (17.4%) and according to the LLN criterion in 23 (9.5%). The overall level of agreement between the two criteria was good (k = 0.67; 95% CI: 0.52-0.81), although it was lower among the individuals ≥ 70 years of age (k = 0.42; 95% CI: 0.12-0.72). The proportion of obese individuals was lower in the GOLD+/LLN+ category than in the GOLD+/LLN- category (p = 0.03), as was the median DLCO (p = 0.04). CONCLUSIONS: The use of the GOLD criterion appears to be associated with a higher prevalence of COPD. The agreement between the GOLD and LLN criteria also appears to be good, albeit weaker in older individuals. The use of different criteria to define airway obstruction seems to identify individuals with different characteristics. It is essential to understand the clinical meaning of discordance between such criteria. Until more data are available, we recommend a holistic, individualized approach to, as well as close follow-up of, patients with discordant results for airway obstruction.


Assuntos
Obstrução das Vias Respiratórias , Doença Pulmonar Obstrutiva Crônica , Idoso , Obstrução das Vias Respiratórias/diagnóstico , Obstrução das Vias Respiratórias/epidemiologia , Obstrução das Vias Respiratórias/etiologia , Volume Expiratório Forçado , Humanos , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Fatores de Risco , Espirometria , Capacidade Vital
6.
J Scleroderma Relat Disord ; 6(2): 178-186, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35386738

RESUMO

Objective: To determine the frequency of elevated D-dimer plasma concentration (>500 ng/mL) in patients with systemic sclerosis and evaluate its association with systemic sclerosis-specific microvascular and macrovascular complications. Methods: Retrospective observational study of patients with systemic sclerosis followed in a tertiary referral center with at least one measurement of D-dimer between 2010 and 2018. Results: A total of 214 patients were analyzed. Mean age at inclusion was 55.1 ± 14.7 years; 180 (84.1%) were female; 74 (34.6%) had diffuse cutaneous systemic sclerosis. Anti-Scl70 and anti-centromere antibodies were positive in 74 (34.6%) and 75 (35.0%) patients, respectively. D-dimer level was elevated in 93 (43.5%) patients, independently of cutaneous subtype (44.6% in diffuse cutaneous systemic sclerosis vs 42.9% in limited cutaneous systemic sclerosis, p = 0.81). At least one microvascular complication was found in 108 (50.5%) patients: 105 (49.1%) with previous or current digital ulcers, 6 (2.8%) with renal crisis, and 4 (1.9%) with pulmonary arterial hypertension. Microvascular complications were more frequent in patients with elevated D-dimer (57.0% vs 45.5%, p = 0.09), significantly so after exclusion of patients with a history of cancer and/or venous thromboembolism (60.5% vs 44.8%, p = 0.04). Macrovascular complications were detected in 15 (7.0%) patients and were associated with a high D-dimer level (11.8% vs 3.3%, p = 0.03). Over a median follow-up of 2.3 years [1.1-3.3] after D-dimer measurement, new macrovascular complications occurred only in patients with high D-dimer (n = 8). Conclusion: High D-dimer levels are frequently found in systemic sclerosis patients and seem to be associated with the occurrence of macrovascular and microvascular complications after adjustment for confounding factors.

7.
J. bras. pneumol ; 47(6): e20210124, 2021. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1356421

RESUMO

ABSTRACT Objective: The identification of persistent airway obstruction is key to making a diagnosis of COPD. The GOLD guidelines suggest a fixed criterion-a post-bronchodilator FEV1/FVC ratio < 70%-to define obstruction, although other guidelines suggest that a post-bronchodilator FEV1/FVC ratio < the lower limit of normal (LLN) is the most accurate criterion. Methods: This was an observational study of individuals ≥ 40 years of age with risk factors for COPD who were referred to our pulmonary function laboratory for spirometry. Respiratory symptoms were also recorded. We calculated the prevalence of airway obstruction and of no airway obstruction, according to the GOLD criterion (GOLD+ and GOLD−, respectively) and according to the LLN criterion (LLN+ and LLN−, respectively). We also evaluated the level of agreement between the two criteria. Results: A total of 241 individuals were included. Airway obstruction was identified according to the GOLD criterion in 42 individuals (17.4%) and according to the LLN criterion in 23 (9.5%). The overall level of agreement between the two criteria was good (k = 0.67; 95% CI: 0.52-0.81), although it was lower among the individuals ≥ 70 years of age (k = 0.42; 95% CI: 0.12-0.72). The proportion of obese individuals was lower in the GOLD+/LLN+ category than in the GOLD+/LLN− category (p = 0.03), as was the median DLCO (p = 0.04). Conclusions: The use of the GOLD criterion appears to be associated with a higher prevalence of COPD. The agreement between the GOLD and LLN criteria also appears to be good, albeit weaker in older individuals. The use of different criteria to define airway obstruction seems to identify individuals with different characteristics. It is essential to understand the clinical meaning of discordance between such criteria. Until more data are available, we recommend a holistic, individualized approach to, as well as close follow-up of, patients with discordant results for airway obstruction.


RESUMO Objetivo: A identificação de obstrução persistente das vias aéreas é fundamental para o diagnóstico de DPOC. As diretrizes da GOLD sugerem um critério fixo - relação VEF1/CVF pós-broncodilatador < 70% - para definir obstrução, embora outras diretrizes sugiram que a relação VEF1/CVF pós-broncodilatador < o limite inferior da normalidade (LIN) é o critério mais preciso. Métodos: Estudo observacional com indivíduos ≥ 40 anos de idade com fatores de risco para DPOC encaminhados ao nosso laboratório de função pulmonar para espirometria. Também foram registrados sintomas respiratórios. Calculamos a prevalência de obstrução e de ausência de obstrução das vias aéreas segundo o critério GOLD (GOLD+ e GOLD−, respectivamente) e segundo o critério LIN (LIN+ e LIN−, respectivamente). Avaliamos também o grau de concordância entre os dois critérios. Resultados: Foram incluídos 241 indivíduos. Obstrução das vias aéreas foi identificada segundo o critério GOLD em 42 indivíduos (17,4%) e segundo o critério LIN em 23 (9,5%). A concordância global entre os dois critérios foi boa (k = 0,67; IC95%: 0,52-0,81), embora tenha sido menor entre os indivíduos ≥ 70 anos de idade (k = 0,42; IC95%: 0,12-0,72). A proporção de obesos foi menor na categoria GOLD+/LIN+ do que na categoria GOLD+/LIN− (p = 0,03), assim como a mediana de DLCO (p = 0,04). Conclusões: A utilização do critério GOLD parece estar associada a uma maior prevalência de DPOC. A concordância entre os critérios GOLD e LIN também parece ser boa, embora seja mais fraca em indivíduos mais velhos. A utilização de diferentes critérios para definir obstrução das vias aéreas parece identificar indivíduos com diferentes características. É essencial compreender o significado clínico da discordância entre esses critérios. Até que mais dados estejam disponíveis, recomendamos uma abordagem holística e individualizada e também um acompanhamento cuidadoso dos pacientes com resultados discordantes para obstrução das vias aéreas.


Assuntos
Humanos , Idoso , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Obstrução das Vias Respiratórias/diagnóstico , Obstrução das Vias Respiratórias/etiologia , Obstrução das Vias Respiratórias/epidemiologia , Espirometria , Capacidade Vital , Volume Expiratório Forçado , Fatores de Risco
8.
Rev Bras Ter Intensiva ; 31(2): 240-247, 2019 Jun 27.
Artigo em Português, Inglês | MEDLINE | ID: mdl-31271627

RESUMO

The fluid resuscitation of patients with acute circulatory failure aims to increase systolic volume and consequently improve cardiac output for better tissue oxygenation. However, this effect does not always occur because approximately half of patients do not respond to fluids. The evaluation of fluid responsiveness before their administration may help to identify patients who would benefit from fluid resuscitation and avoid the risk of fluid overload in the others. The dynamic parameters of fluid responsiveness evaluation are promising predictive factors. Of these, the echocardiographic measurement of the respiratory variation in the inferior vena cava diameter is easy to apply and has been used in the hemodynamic evaluation of intensive care unit patients. However, the applicability of this technique has many limitations, and the present studies are heterogeneous and inconsistent across specific groups of patients. We review the use of the inferior vena cava diameter respiratory variation, measured via transthoracic echocardiography, to decide whether to administer fluids to patients with acute circulatory failure in the intensive care unit. We explore the benefits and limitations of this technique, its current use, and the existing evidence.


A ressuscitação hídrica do paciente em falência circulatória aguda tem como um de seus objetivos aumentar o volume sistólico e, consequentemente, o débito cardíaco, para melhor oxigenação dos tecidos. Contudo, isso não se verifica em cerca de metade dos pacientes, que são considerados não respondedores a fluidos. A avaliação da resposta a fluidos antes de sua administração pode selecionar os pacientes que devem ter benefício e evitar o risco de sobrecarga nos restantes. Os parâmetros dinâmicos de avaliação da resposta a fluidos têm se revelado promissores enquanto fatores preditores. Entre estes, a medição ecocardiográfica da variação respiratória do diâmetro da veia cava inferior é um método de fácil aplicação, que tem sido difundido na avaliação hemodinâmica em unidades de cuidados intensivos. No entanto, a aplicabilidade desta técnica tem muitas limitações, e os estudos, até à presente data, são heterogêneos e pouco consistentes em alguns grupos de pacientes. Realizamos uma revisão sobre a utilização da variação respiratória do diâmetro da veia cava inferior, medida por ecocardiografia transtorácica, na decisão de administrar fluidos ao paciente em falência circulatória aguda, em cuidados intensivos, incluindo potencialidades e limitações da técnica, de sua interpretação e a evidência existente.


Assuntos
Tomada de Decisão Clínica/métodos , Cuidados Críticos/métodos , Hidratação , Ressuscitação , Choque/terapia , Veia Cava Inferior/diagnóstico por imagem , Doença Aguda , Ecocardiografia , Humanos , Veia Cava Inferior/fisiologia
9.
Rev. bras. ter. intensiva ; 31(2): 240-247, abr.-jun. 2019. tab, graf
Artigo em Português | LILACS | ID: biblio-1013771

RESUMO

RESUMO A ressuscitação hídrica do paciente em falência circulatória aguda tem como um de seus objetivos aumentar o volume sistólico e, consequentemente, o débito cardíaco, para melhor oxigenação dos tecidos. Contudo, isso não se verifica em cerca de metade dos pacientes, que são considerados não respondedores a fluidos. A avaliação da resposta a fluidos antes de sua administração pode selecionar os pacientes que devem ter benefício e evitar o risco de sobrecarga nos restantes. Os parâmetros dinâmicos de avaliação da resposta a fluidos têm se revelado promissores enquanto fatores preditores. Entre estes, a medição ecocardiográfica da variação respiratória do diâmetro da veia cava inferior é um método de fácil aplicação, que tem sido difundido na avaliação hemodinâmica em unidades de cuidados intensivos. No entanto, a aplicabilidade desta técnica tem muitas limitações, e os estudos, até à presente data, são heterogêneos e pouco consistentes em alguns grupos de pacientes. Realizamos uma revisão sobre a utilização da variação respiratória do diâmetro da veia cava inferior, medida por ecocardiografia transtorácica, na decisão de administrar fluidos ao paciente em falência circulatória aguda, em cuidados intensivos, incluindo potencialidades e limitações da técnica, de sua interpretação e a evidência existente.


ABSTRACT The fluid resuscitation of patients with acute circulatory failure aims to increase systolic volume and consequently improve cardiac output for better tissue oxygenation. However, this effect does not always occur because approximately half of patients do not respond to fluids. The evaluation of fluid responsiveness before their administration may help to identify patients who would benefit from fluid resuscitation and avoid the risk of fluid overload in the others. The dynamic parameters of fluid responsiveness evaluation are promising predictive factors. Of these, the echocardiographic measurement of the respiratory variation in the inferior vena cava diameter is easy to apply and has been used in the hemodynamic evaluation of intensive care unit patients. However, the applicability of this technique has many limitations, and the present studies are heterogeneous and inconsistent across specific groups of patients. We review the use of the inferior vena cava diameter respiratory variation, measured via transthoracic echocardiography, to decide whether to administer fluids to patients with acute circulatory failure in the intensive care unit. We explore the benefits and limitations of this technique, its current use, and the existing evidence.


Assuntos
Humanos , Ressuscitação , Choque/terapia , Veia Cava Inferior/diagnóstico por imagem , Cuidados Críticos/métodos , Hidratação , Tomada de Decisão Clínica/métodos , Veia Cava Inferior/fisiologia , Ecocardiografia , Doença Aguda
10.
Diabetes Res Clin Pract ; 147: 93-101, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30481576

RESUMO

AIMS: Clinical risk factors and bone mineral densitometry underestimate low-energy fracture (LEF) risk in people with diabetes. We aim to estimate the prevalence of LEF in diabetics, compare with nondiabetics; and evaluate possible predictors of LEF in people with diabetes. METHODS: Cross-sectional, population-based study in Portuguese subjects over 40 years-old. Estimates computed as weighted proportions/means, considering sample design. Multivariate logistic regression models to evaluate the association of diabetes and LEF; and predictors of LEF in diabetics. RESULTS: 7675 subjects were analysed, of which 1173 reported diabetes. Diabetics were older (mean age 66.0 ±â€¯11.49y), more frequently reported osteoporosis and falls in the previous 12 months (32.4% vs. 22.9%). Prevalence of self-reported LEF was 16.2% (95% CI:13.68-19.13) among diabetics (vs. 13.3%, 95% CI:12.14-14.57, in nondiabetics); OR for the association diabetes and LEF:1.26, 95% CI:1.01-1.58, p = 0.045 (in women, adjusted OR:1.41, 95% CI:1.05-1.89, p = 0.02). Thirty percent of diabetics reported at least one major LEF and 70% in other sites. In diabetics, LEF was independently associated with self-reported osteoporosis and falls in the previous 12 months. CONCLUSION: People with diabetes reported more falls and had higher prevalence of self-reported LEF. Self-reported osteoporosis and falls were associated with LEF in diabetics. Our findings emphasize the need for fracture and falls preventive measures in diabetics.


Assuntos
Complicações do Diabetes/complicações , Fraturas Ósseas/etiologia , Adulto , Idoso , Estudos Transversais , Feminino , Fraturas Ósseas/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Projetos de Pesquisa , Fatores de Risco , Autorrelato
11.
Breathe (Sheff) ; 13(3): e72-e78, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28955408

RESUMO

Can you diagnose this right-sided pleuritic chest pain? http://ow.ly/yYq230dDqcd.

12.
Rev Port Pneumol ; 14(5): 677-86, 2008.
Artigo em Português | MEDLINE | ID: mdl-18781267

RESUMO

Tuberculosis of the breast is an uncommon disease. The authors present a case of an asymptomatic 64 year-old patient whose mammography showed a right breast nodule which needed aetiological investigation. Complementary diagnostic exams did not lead to a differential diagnosis between granulomatous lesion and breast carcinoma; nodule aspiration results suggested tuberculosis of the breast but were unclear and so tuberculosis antibiotics were initiated. No other tuberculosis infectious focus was found at clinical- laboratory evaluation. Imagiology progress was favourable, so patient continued treatment. The authors highlight the low rate of primary tuberculosis of the breast and make a brief reference to the pathology, which has a low rate of microbiological and pathological- anatomical identification.


Assuntos
Doenças Mamárias/microbiologia , Tuberculose Endócrina , Doenças Mamárias/diagnóstico , Doenças Mamárias/terapia , Feminino , Humanos , Pessoa de Meia-Idade , Tuberculose Endócrina/diagnóstico , Tuberculose Endócrina/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...